免疫衰老
失调
肠道菌群
免疫学
免疫原性
接种疫苗
医学
免疫系统
冠状病毒
疾病
疫苗效力
2019年冠状病毒病(COVID-19)
内科学
传染病(医学专业)
作者
Seung Keun Oh,Haesook Seo
出处
期刊:Heliyon
[Elsevier BV]
日期:2023-05-01
卷期号:9 (5): e15668-e15668
被引量:1
标识
DOI:10.1016/j.heliyon.2023.e15668
摘要
Dysbiosis of the gut microbiota with aging contributes to a reduction in important cross-feeding bacterial reactions in the gut and immunosenescence, which could contribute to a decrease in vaccine efficacy. Fever, cough, and fatigue are the main signs of coronavirus disease 2019 (COVID-19); however, some patients with COVID-19 present with gastrointestinal symptoms. COVID-19 vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is one of the best measures to reduce SARS-CoV-2 infection rates and the severity of COVID-19. The immunogenicity of COVID-19 vaccines is influenced by the composition of the gut microbiota, and the immune response to COVID-19 vaccines decreases with age. In this review, we discuss gut microbiota dysbiosis and immunosenescence in the older adults, the role of gut microbiota in improving the efficacy of COVID-19 vaccines, and dietary interventions to improve the efficacy of COVID-19 vaccines in the older adults.
科研通智能强力驱动
Strongly Powered by AbleSci AI